MoFo Global PE Trends 2024 and Outlook for 2025

MoForum: Bayer Co.Lab Edition – Charting the Biotech Startup Journey

Update February 2024 on Commission Plans Liberalization of New Genomic Techniques (NGTS) in the EU

EU AI Act – Landmark Law on Artificial Intelligence Approved by the European Parliament

MoFo Global PE Trends 2023 and Outlook for 2024

Interpreting the EU’s Political Agreement on the AI Act: What Does It Mean and What’s Next?

MoFo and Bayer Co.Lab Kick-Off Partnership to Advance Cell and Gene Therapy Innovation

Commission Plans Liberalization of New Genomic Techniques (NGTs) in the EU

10 Considerations When Licensing AI For Drug Discovery

The Unified Patent Court: Opting European Patents Out

EU MDR and IVDR Implementation: European Commission Publishes Full Proposal for Amending Transitional Regime

EU MDR and IVDR Implementation: Signs of Relaxing Transitioning Regime and Bridging Measures

EU: In Vitro Diagnostic Regulation Entered Into Force (Part 3 of 3)

EU: In Vitro Diagnostic Regulation Entered into Force (Part 2 of 3)

EU: In Vitro Diagnostic Regulation Entered into Force (Part 1 of 3)